Languages
  • Deutsch
  • English
  • Home
  • About ESfEQA
  • EQA Programs
    • Biochemistry
    • Immunology
    • Microbiology
    • Molecular Diagnostics
    • Hematology
    • Instructions for Participants
    • Catalogue, Calendar
  • Distributors
  • Contact
  • Biochemistry
  • Immunology
  • Microbiology
    • Adenovirus
    • Aspergillus Fumigatus
    • Bacteriology
    • Borrelia
    • Brucella
    • Chagas
    • Chikungunya Virus
    • Chlamydophila Pneumoniae
    • Chlamydia Trachomatis
    • Coxsackievirus
    • Dengue Virus
    • ECHO-Virus
    • Enterovirus
    • Epstein-Barr Virus
    • Hepatitis A Virus
    • Hepatitis B Virus
    • Hepatitis E Virus
    • HTLV I/II
    • Infectious Disease Combination Control
    • Influenza A Virus
    • Influenza B Virus
    • Leptospira
    • Malaria Microscopy
    • Measles
    • Mosquito Transmitted Diseases
    • Parainfluenza Virus
    • Parvovirus B19
    • Respiratory Syncytial Virus
    • SARS-CoV-2 (COVID-19) Antibodies
    • SARS-CoV-2 (COVID-19) Antigen
    • Syphilis
    • ToRCH
    • Varizella Zoster Virus
    • West Nile Virus
    • Zika Virus
  • Molecular Diagnostics
  • Hematology
  • Instructions for Participants
  • Catalogue, Calendar

SARS-CoV-2 (COVID-19) Antibodies

4 liquid samples (minumum 0,3 ml) of human plasma.

4 surveys per year. This program is not accredited according to DIN EN ISO/IEC 17043:2010.

Analytical parameters

IgA, IgG, IgM and antibodies total against SARS-CoV-2

Instructions for Use

IFU_COVID_2020_02

Fax Data Entry Form

Fax-Form_COVID_2020_02

Short name

COVID

ESfEQA Flyer:

SARS-CoV-2 (COVID-19) Antibodies

SitemapDisclaimerGeneral Terms
© 2021 ESfEQA GmbH